Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Identification of Cytochromes P450 Involved in the Human Liver Microsomal Metabolism of the Thromboxane A2 Inhibitor Seratrodast (ABT-001)

Gondi N. Kumar, Erik Dubberke, A. David Rodrigues, Ellen Roberts and Jon F. Dennisen
Drug Metabolism and Disposition January 1997, 25 (1) 110-115;
Gondi N. Kumar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erik Dubberke
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. David Rodrigues
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ellen Roberts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jon F. Dennisen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 25 no. 1 110-115
PubMed 
9010637

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received June 28, 1996
  • Accepted October 10, 1996
  • Published online January 1, 1997.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Gondi N. Kumar,
  2. Erik Dubberke,
  3. A. David Rodrigues,
  4. Ellen Roberts and
  5. Jon F. Dennisen
  1. Biotransformation Department, Abbott Laboratories
    View Full Text

    Statistics from Altmetric.com

    Article usage

    Article usage: August 2017 to May 2023

    AbstractFullPdf
    Aug 2017095
    Sep 20171133
    Oct 201702012
    Nov 2017272
    Dec 201702743
    Jan 201802692
    Feb 201831541
    Mar 201841191
    Apr 20183692
    May 20180480
    Jun 20180353
    Jul 20181143
    Aug 20181144
    Sep 20180223
    Oct 20180430
    Nov 20181453
    Dec 201845124
    Jan 20194221
    Feb 20194020
    Mar 20191510
    Apr 20192300
    May 2019611
    Jun 2019202
    Jul 20191000
    Aug 20191011
    Oct 2019600
    Nov 2019900
    Dec 20191442
    Jan 2020811
    Feb 20201111
    Mar 20201523
    May 2020200
    Jun 2020300
    Jul 2020411
    Aug 2020003
    Sep 2020300
    Oct 20201100
    Nov 2020700
    Dec 20201123
    Jan 20211571
    Feb 2021461
    Mar 2021441
    Apr 2021421
    May 20211830
    Jun 20211871
    Jul 20211110
    Aug 20211752
    Sep 2021971
    Oct 2021840
    Nov 20213110
    Dec 20211342
    Jan 2022410
    Feb 2022632
    Mar 2022310
    Apr 2022760
    May 2022711
    Jun 20221010
    Jul 20221621
    Aug 2022510
    Sep 2022630
    Oct 20221520
    Nov 20221511
    Dec 20221010
    Jan 20231740
    Feb 2023341
    Mar 20231010
    Apr 2023710
    May 20232510

    PreviousNext
    Back to top

    In this issue

    Drug Metabolism and Disposition
    Vol. 25, Issue 1
    1 Jan 1997
    • Table of Contents
    • Index by author
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for sharing this Drug Metabolism & Disposition article.

    NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

    Enter multiple addresses on separate lines or separate them with commas.
    Identification of Cytochromes P450 Involved in the Human Liver Microsomal Metabolism of the Thromboxane A2 Inhibitor Seratrodast (ABT-001)
    (Your Name) has forwarded a page to you from Drug Metabolism & Disposition
    (Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    Research ArticleArticle

    Identification of Cytochromes P450 Involved in the Human Liver Microsomal Metabolism of the Thromboxane A2 Inhibitor Seratrodast (ABT-001)

    Gondi N. Kumar, Erik Dubberke, A. David Rodrigues, Ellen Roberts and Jon F. Dennisen
    Drug Metabolism and Disposition January 1, 1997, 25 (1) 110-115;

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

    Share
    Research ArticleArticle

    Identification of Cytochromes P450 Involved in the Human Liver Microsomal Metabolism of the Thromboxane A2 Inhibitor Seratrodast (ABT-001)

    Gondi N. Kumar, Erik Dubberke, A. David Rodrigues, Ellen Roberts and Jon F. Dennisen
    Drug Metabolism and Disposition January 1, 1997, 25 (1) 110-115;
    Reddit logo Twitter logo Facebook logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
      • Abstract
      • Results
      • Discussion
      • Footnotes
      • References
    • Figures & Data
    • Info & Metrics
    • eLetters
    • PDF

    Related Articles

    Cited By...

    More in this TOC Section

    • Sex- and lifestyle-related factors affect hepatic CYP levels
    • Adipocyte PXR does not play an essential role in obesity.
    • CYP3A-mediated oxidation of DABE and BIBR0951
    Show more Article

    Similar Articles

    Advertisement
    • Home
    • Alerts
    Facebook   Twitter   LinkedIn   RSS

    Navigate

    • Current Issue
    • Fast Forward by date
    • Fast Forward by section
    • Latest Articles
    • Archive
    • Search for Articles
    • Feedback
    • ASPET

    More Information

    • About DMD
    • Editorial Board
    • Instructions to Authors
    • Submit a Manuscript
    • Customized Alerts
    • RSS Feeds
    • Subscriptions
    • Permissions
    • Terms & Conditions of Use

    ASPET's Other Journals

    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    ISSN 1521-009X (Online)

    Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics